Recombinant IL-2 therapies in the clinic for cancer & HIV

被引:0
|
作者
Pramik, MJ
机构
来源
GENETIC ENGINEERING NEWS | 1997年 / 17卷 / 19期
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1 / &
相关论文
共 50 条
  • [1] THE DEVELOPMENT OF ANTI-INTERLEUKIN-2 (IL-2) ANTIBODIES IN CANCER-PATIENTS TREATED WITH RECOMBINANT IL-2
    SCHARENBERG, JGM
    STAM, AGM
    VONBLOMBERG, BME
    ROEST, GJ
    PALMER, PA
    FRANKS, CR
    MEIJER, CJLM
    SCHEPER, RJ
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) : 1804 - 1809
  • [2] THE PHARMACOKINETICS OF RECOMBINANT IL-2 IN RABBITS
    KONRAD, M
    CHILDS, A
    BRADLEY, EC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 302 - 302
  • [3] EFFECTS OF RECOMBINANT IL-2 ON HEMATOPOIESIS
    RANKIN, CD
    HOUWEN, B
    LAFRENIERE, R
    BORKENHAGEN, K
    WELLINGS, M
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : B83 - B83
  • [4] ADMINISTRATION OF RECOMBINANT IL-2 AUGMENTS THE LEVEL OF SERUM IGM IN AN IL-2 DEFICIENT PATIENT
    DOI, S
    SAIKI, O
    HARA, T
    SUGITA, T
    HAKAWA, K
    TANAKA, T
    HARA, H
    NEGORO, S
    YABUUCHI, H
    KISHIMOTO, S
    EUROPEAN JOURNAL OF PEDIATRICS, 1989, 148 (07) : 630 - 633
  • [5] Cytokine-based therapies in HIV infection: Lessons from IL-2 and expectations from IL-7
    Sereti, Irini
    CYTOKINE, 2010, 52 (1-2) : 100 - 100
  • [6] IL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?
    Tomala, Jakub
    Kovar, Marek
    ONCOIMMUNOLOGY, 2016, 5 (03):
  • [7] IS THE TOXICITY OF RECOMBINANT IL-2 MEDIATED BY LAK CELLS
    GATELY, MK
    MCFEETERS, G
    ANDERSON, TD
    HAYES, TJ
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 788 - 788
  • [8] THE EFFECTS OF RECOMBINANT HUMAN IL-2 IN MINIATURE SWINE
    NAKAJIMA, K
    SMITH, CV
    MIXON, A
    ROSENGARD, BR
    GUZZETTA, PC
    SPITZER, TR
    ECKHAUS, MA
    SACHS, DH
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 248 - 250
  • [9] SUPPRESSION OF MONOCYTE AND NEUTROPHIL FUNCTION BY RECOMBINANT IL-2
    SMITH, SE
    WARREN, GD
    THONG, YH
    MCCORMACK, JG
    MEDIATORS OF INFLAMMATION, 1993, 2 (01) : 59 - 65
  • [10] EFFECTS OF SUBCUTANEOUS RECOMBINANT IL-2 ON HUMORAL IMMUNITY IN ADVANCED CANCER-PATIENTS
    CASAMASSIMA, A
    GUIDA, M
    LATORRE, A
    ABBATE, I
    TRIANTAFILLOU, V
    MUSCI, M
    DELENA, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 3 (02) : 171 - 176